NCT02700347View on ClinicalTrials.gov

Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Tuberculosis
Interventions
DRUG

Pyrazinamide

DRUG

Allopurinol

Trial Locations (1)

Unknown

National University Hospital, Singapore, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT02700347 - Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers | Biotech Hunter | Biotech Hunter